Healthcare CEO Guide: What Your Board or Partners Must Decide Before LOI
Healthcare CEO Guide: What Your Board or Partners Must Decide Before LOI Key Takeaways Why Alignment Must Happen Before LOI An LOI should confirm a shared strategy, not expose internal conflict. In 2025, 47% of directors said M&A was a strategic priority for their boards, showing how early governance matters in real transactions. Buyers also […]
Read More
How Healthcare Advisors Help Healthcare CEOs Protect Culture While Still Maximizing Price
How Healthcare Advisors Help Healthcare CEOs Protect Culture While Still Maximizing Price Key Takeaways Why “Culture vs. Price” Is a False Tradeoff Buyers Pay More for Stability They Can Underwrite Healthcare deals don’t reward chaos. Buyers pay more when performance stays steady, leadership remains trusted, and clinical standards feel durable. Advisors protect culture by […]
Read More
How to Protect Your Healthcare Company’s Legacy While Still Maximizing Price (Section 1/3)
How to Protect Your Healthcare Company’s Legacy While Still Maximizing Price (Section 1/3) Key Takeaways Why “Legacy vs. Price” Is a False Tradeoff in 2026 Healthcare M&A Buyers don’t only purchase EBITDA—they underwrite risk, retention, and continuity. If your brand, clinicians, and patient experience are fragile, the price gets discounted. If they’re durable, multiples rise. […]
Read More
Healthcare M&A Firms vs Investment Banks: What CEOs Need to Understand
Healthcare M&A Firms vs Investment Banks: What CEOs Need to Understand Key Takeaways Understanding the Landscape of Healthcare M&A Mergers and acquisitions in healthcare are more complex than in most other industries. CEOs and practice owners face unique challenges: strict regulatory environments, evolving reimbursement models, and highly specialized buyers such as DSOs, MSOs, and private […]
Read More